CCN2 and Hepatic fibrosis: To determine whether the serum level of CTGF is correlated with the progression of liver fibrosis in patients with FALD, we examined patients with FALD because no reliable fibrosis marker has been established for these patients and noninvasive fibrosis estimation methods are in high demand [15].